Get started
Live feed
PRReleasevia Quantisnow
AbbVie Inc. logo

AbbVie Reports Third-Quarter 2026 Financial Results

ByQuantisnow··Wall Street's wire, on your screen.
Stocks in this Quantisnow insight

Historical context for ABBV

Across the 18 sessions after earlier ABBV headlines, the stock closed higher 10 times and lower 8 times, with a median move of 0.7% in either direction. This shows timing only: many things move a stock in a session, and these figures do not show that any headline caused a move.

ABBV close-to-close change in the session after earlier headlines
SessionEarlier headlineABBVSPY
Oct 29, 2026AbbVie TEMPLE Study Demonstrates Superior Tolerability and Efficacy of Atogepant (QULIPTA®) in Head-to-Head Migraine Prevention Trial+1.7%-0.4%
Oct 28, 2026The Countdown Is On: BOTOX® Cosmetic (onabotulinumtoxinA) Day is Back Nov. 18-0.1%+0.3%
Oct 27, 2026Allergan Aesthetics Announces 2026 Grant Recipients of The Confidence Collective, Funded by BOTOX® Cosmetic (onabotulinumtoxinA)and 1 other headline that session-0.1%+0.6%
Oct 26, 2026Allergan Aesthetics Celebrates Eight Years of Engaging Girls in STEM Through Continued Partnership with Girls Inc.and 2 other headlines that session+0.4%+0.7%
Oct 23, 2026U.S. FDA Approves Subcutaneous Induction Regimen for AbbVie's SKYRIZI® (risankizumab-rzaa) for Adults With Moderately to Severely Active Crohn's Disease+0.2%-0.5%
Oct 22, 2026AbbVie Announces Topline Results from the Phase 3 INTREPID Trial Showing Lutikizumab Significantly Improved Signs and Symptoms of Disease in Patients with Hidradenitis Suppurativa+0.1%-1.2%
Quantisnow market dataNYSE
AbbVie Inc. logo
ABBV
AbbVie Inc.
Market cap
30-day
Sector
Health Care
Industry
Biotechnology: Pharmaceutical Preparations
Listed since
2012
Get push alerts for ABBV

Follow ABBV and get a push notification the moment its next story breaks.

Full ABBV profile on Quantisnow

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ABBV (AbbVie Inc.) and more on Quantisnow.